AMPLATZER DUCT OCCLUDER 9-PDA-006

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2019-04-12 for AMPLATZER DUCT OCCLUDER 9-PDA-006 manufactured by Aga Medical Corporation.

Event Text Entries

[141915801] Acute ascending aortic dissection was reported in an article. In a retrospective review, the amplatzer duct occluder "may have been slightly deformed. " the results of the investigation are inconclusive since the device was not returned for analysis. Based on the information received, the cause of the reported incident could not be conclusively determined. According to the article, other contributing factors may have been "damage to the aortic wall due to the aortic side of the device, uneven elasticity of the arterial wall, and uncontrolled excessively high blood pressure. "
Patient Sequence No: 1, Text Type: N, H10


[141915802] The following was published in the journal of cardiology in an article titled: "acute ascending aortic dissection due to transcatheter patent ductus arteriosus closure in the elderly: an extremely rare complication of transcatheter patent ductus arteriosus closure. " a (b)(6) woman with a pda with focal calcification at the aortic orifice of the ampulla with a minimum diameter of 4. 0 mm and length of 14. 8 mm, was treated with a 10/8-mm amplatzer duct occluder (ado) (st. Jude medical corp, st. Paul, mn, usa). After device implantation, systolic blood pressure (bp) increased to approximately 220 mmhg from 130 mmhg. She experienced transient dyspnea from hypertensive heart failure, which improved through continuous infusion of antihypertensive agents. She suddenly felt pressure on her chest 12 h post-procedure and collapsed. Surgical thoracotomy revealed an ascending aortic dissection into the pericardial space. In retrospective review, the ado may have been slightly deformed by fluoroscopy. The complication may have been triggered by the resilience caused by device deformation, damage to the aortic wall due to the aortic side of the device, uneven elasticity of the arterial wall, and uncontrolled excessively high blood pressure. Ascending aortic replacement was performed and she recovered without neurological deficits. Yamamoto h, shinke t, otake h, tanaka h, matsumoto k, hirata k-i. "acute ascending aortic dissection due to transcatheter patent ductus arteriosus closure in the elderly: an extremely rare complication of transcatheter patent ductus arteriosus closure. " journal of cardiology cases. Doi:10. 1016/j. Jccase. 2018. 12. 002.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2135147-2019-00101
MDR Report Key8511878
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2019-04-12
Date of Report2019-04-12
Date Mfgr Received2019-03-26
Date Added to Maude2019-04-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHANIE O' SULLIVAN
Manufacturer Street5050 NATHAN LANE NORTH
Manufacturer CityPLYMOUTH MN 55442
Manufacturer CountryUS
Manufacturer Postal55442
Manufacturer Phone6517565400
Manufacturer G1AGA MEDICAL CORPORATION
Manufacturer Street5050 NATHAN LANE NORTH
Manufacturer CityPLYMOUTH MN 55442
Manufacturer CountryUS
Manufacturer Postal Code55442
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAMPLATZER DUCT OCCLUDER
Generic NameOCCLUDER, PATENT DUCTUS, ARTERIOSUS
Product CodeMAE
Date Received2019-04-12
Model Number9-PDA-006
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerAGA MEDICAL CORPORATION
Manufacturer Address5050 NATHAN LANE NORTH PLYMOUTH MN 55442 US 55442


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-04-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.